Literature DB >> 24673069

[Thinking on designation of sham acupuncture in clinical research].

Li-Jia Pan, Bo Chen, Xue Zhao, Yi Guo.   

Abstract

Randomized controlled trials (RCT) is the source of the raw data of evidence-based medicine. Blind method is adopted in most of the high-quality RCT. Sham acupuncture is the main form of blinded in acupuncture clinical trial. In order to improve the quality of acupuncture clinical trail, based on the necessity of sham acupuncture in clinical research, the current situation as well as the existing problems of sham acupuncture, suggestions were put forward from the aspects of new way and new designation method which can be adopted as reference, and factors which have to be considered during the process of implementing. Various subjective and objective factors involving in the process of trial should be considered, and used of the current international standards, try to be quantification, and carry out strict quality monitoring.

Mesh:

Year:  2014        PMID: 24673069

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  3 in total

Review 1.  Sham Acupressure Controls Used in Randomized Controlled Trials: A Systematic Review and Critique.

Authors:  Jing-Yu Tan; Lorna K P Suen; Tao Wang; Alexander Molassiotis
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

2.  The efficacy of traditional acupuncture on patients with chronic neck pain: study protocol of a randomized controlled trial.

Authors:  Yiling Yang; Xiaoxia Yan; Hongmei Deng; Dian Zeng; Jianpeng Huang; Wenbin Fu; Nenggui Xu; Jianhua Liu
Journal:  Trials       Date:  2017-07-10       Impact factor: 2.279

3.  An Evidence-Based Somatic Acupressure Intervention Protocol for Managing the Breast Cancer Fatigue-Sleep Disturbance-Depression Symptom Cluster: Development and Validation following the Medical Research Council Framework.

Authors:  Jing-Yu Benjamin Tan; Tao Wang; Isabella Zhao; Mary Janice Polotan; Sabina Eliseeva
Journal:  Int J Environ Res Public Health       Date:  2022-09-21       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.